fbpx
IMAC Holdings Completes First Infusion of Stem Cells in Clinical Study for the Treatment of Bradykinesia Due to Parkinson’s Disease

IMAC Holdings Completes First Infusion of Stem Cells in Clinical Study for the Treatment of Bradykinesia Due to Parkinson’s Disease

BRENTWOOD, Tenn. (December 30, 2020) — IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids,...
DOCTOR’S NOTES: Let’s talk about Neuropathy

DOCTOR’S NOTES: Let’s talk about Neuropathy

“Doctor, I can’t go living on like this!”, “I can’t feel my feet very well!” Unfortunately, we hear this from patients all too often from patients with neuropathy. The problem is often misdiagnosed, not diagnosed at all, or there is nothing that can be done except to...